BioStem Technologies to Acquire Majority of Assets of Auxocell Laboratories, Inc.
07 mars 2023 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., March 07, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company”) (OTCQB: BSEM), announced today that it has entered into an Agreement to acquire the...
BioStem Technologies Poised for Growth with Two New Hires: Michael Sylvester Joins as Vice President of Sales, Neal Bhattacharya as Vice President of Marketing
01 févr. 2023 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Feb. 01, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company) (OTCQB: BSEM), a leading regenerative medicine company focused on the development,...
Center for Medicare Services Established National Pricing of VENDAJETM in All MAC regions
24 janv. 2023 07h30 HE
|
BioStem Technologies, Inc.
Pricing Provides VENDAJETM Reimbursement in All MAC Regions POMPANO BEACH, FLORIDA., Jan. 24, 2023 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTCQB: BSEM), a leading regenerative medicine...
BioStem Technologies Announces Up-Listing to the OTCQB Venture Market
16 déc. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Dec. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTCQB: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Technologies Announces Partnership with Kill Cliff FC
14 déc. 2022 07h30 HE
|
BioStem Technologies, Inc.
Kill Cliff FC is One of the world’s largest MMA Training Centers with More Than 80 Professional Fighters POMPANO BEACH, FLORIDA., Dec. 14, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC:...
BioStem Technologies to Host Third Quarter Financial Results and Corporate Update Conference Call
15 nov. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Nov. 15, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer
26 oct. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Oct. 26, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company) (OTC PINK: BSEM), a leading regenerative medicine company focused on the development,...
BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference
10 oct. 2022 07h30 HE
|
BioStem Technologies, Inc.
POMPANO BEACH, FLORIDA., Oct. 10, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC PINK: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
BioStem Announces Publication of a Standardized Method to Evaluate Growth Factor Elution from Placental Tissue Allografts
13 sept. 2022 07h30 HE
|
BioStem Technologies, Inc.
Standardized methodology demonstrates high presence of placental membrane growth factors in BioStem’s Vendaje® and Vendaje AC® tissue allografts POMPANO BEACH, FLORIDA., Sept. 13, 2022 (GLOBE...
BioStem Technologies Reports Second Quarter 2022 Operating and Financial Results
22 août 2022 16h01 HE
|
BioStem Technologies, Inc.
Company to Host a Conference Call and Webcast on August 22, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Aug. 22, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading...